| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||
Net loss | ||||||||
-168,822 | -113,217 | -69,824 | -71,090 | -50,574 | -36,459 | -35,972 | -33,334 | -21,736 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Share-based compensation expense | ||||||||
9,294 | 7,107 | 5,295 | 4,182 | 4,559 | 1,828 | 2,050 | 2,243 | 1,610 |
Loss on early extinguishment of debt | ||||||||
- | 0 | -293 | -0 | -1,208 | - | - | - | - |
Loss from remeasurement of development derivative liability | ||||||||
-68,406 | -4,736 | -263 | -9,104 | -736 | - | - | - | - |
Amortization of right-of-use assets | ||||||||
57 | - | 77 | 75 | 73 | - | - | - | - |
Depreciation expense | ||||||||
85 | 86 | 65 | 46 | 41 | - | - | - | - |
Amortization of debt discounts | ||||||||
- | - | - | - | 19 | - | - | - | - |
Amortization of term loan facility discounts | ||||||||
- | - | - | - | 104 | - | - | - | - |
Amortization of discounts for convertible notes, net of financing costs | ||||||||
1,994 | - | - | - | - | - | - | - | - |
Accretion of discounts for promissory note | ||||||||
- | - | - | - | - | 18 | 18 | 17 | 17 |
Accretion of discounts for term loan facility | ||||||||
- | - | - | - | - | 118 | 126 | 127 | 208 |
Changes in operating assets and liabilities: | ||||||||
Refundable research and development credit | ||||||||
- | - | - | - | - | -142 | 543 | -168 | -531 |
Prepaid assets | ||||||||
3,004 | 5,059 | 765 | -6,532 | -3,824 | 7,478 | 5,998 | 2,735 | 3,062 |
Other current assets | ||||||||
671 | -1,171 | -2,155 | 2,790 | 250 | 296 | 20 | -195 | 188 |
Other assets | ||||||||
460 | 202 | 28 | 45 | 46 | - | - | - | - |
Accounts payable | ||||||||
-5,237 | -3,433 | -2,008 | 1,894 | 1,906 | 4,792 | 325 | 547 | 921 |
Accrued expenses | ||||||||
-9,991 | 24,908 | 10,145 | 12,635 | 2,764 | -5,461 | 5,465 | 2,411 | -180 |
Other liabilities | ||||||||
- | -250 | 0 | 15 | 76 | - | - | 0 | 5 |
Net cash used in operating activities | ||||||||
-108,349 | -82,071 | -53,597 | -39,906 | -35,560 | -44,478 | -33,132 | -30,694 | -22,935 |
Investing Activities | ||||||||
Purchase of property and equipment | ||||||||
435 | 155 | 470 | 192 | 875 | - | - | - | - |
Purchase of available-for-sale securities | ||||||||
227,419 | - | - | - | - | - | - | - | - |
Net cash used in investing activities | ||||||||
-227,854 | -155 | -470 | -192 | -875 | - | - | - | - |
Deferred issuance costs | ||||||||
- | - | - | - | - | - | - | - | 2 |
Proceeds from issuance of common stock, net of issuance costs | ||||||||
381,593 | -658 | 0 | 312 | 109,927 | - | - | - | - |
Proceeds from development derivative liability | ||||||||
20,000 | 0 | 20,000 | 40,000 | 60,000 | - | - | - | - |
Proceeds from exercise of stock options | ||||||||
1,674 | - | 929 | 1,262 | 192 | - | 114 | 275 | 225 |
Repayment of term loan facility | ||||||||
- | 0 | 0 | 0 | 21,701 | - | - | - | - |
Net cash provided by financing activities | ||||||||
403,267 | 209 | 198,949 | 40,964 | 148,418 | 115 | -38 | 131,603 | 222 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||||
-152 | 8 | -15 | 16 | -4 | - | - | - | - |
Net increase in cash, cash equivalents and restricted cash | ||||||||
66,912 | -82,009 | 144,866 | 881 | 111,979 | -44,373 | -33,198 | 100,908 | -22,712 |
Cash paid for Interest | ||||||||
3,829 | 28 | 230 | 140 | 588 | 477 | 330 | 456 | 551 |